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he clinician proposes a pharmacological treat-
ment to patients when he or she concludes that such a
treatment is warranted:the clinician should,ideally,write
prescriptions on the basis of the prediction of the bene-
fits and risks of the drug (or psychotherapeutic,or social)
treatment for each given patient.The actual evolution
once the patient has been taking the treatment should
correspond as closely as possible to the previously made
prediction.In statistical terms,the clinician should pre-
dict much of the variance of drug response;and should
achieve a high predictive accuracy (defined by the sum
of the correct predictions divided by the total number of
predictions).In colloquial terms,the goal is to know with
little doubt that one is “betting a horse that will be the
winner—or among the winners.”
The prediction of outcome is a prerequisite to personal-
ized therapy,ie,a treatment chosen on the basis of the
patient characteristics.Several steps precede this choice
of therapy.A diseased state has to be recognized as such
by both the patient and the physician;a diagnosis should
be made in accordance with the profile of complaints
and symptoms,as well as with classification criteria;the
severity of the disorder should be correctly assessed;and
a prognosis should be made. Misunderstanding, igno-
rance,or error can occur at each of these steps,leading
to a decreased accuracy of the predictions of outcome,as
well as to a decrease in the usefulness of therapy.These
issues are the domains of studies on the rate of recogni-
tion of diagnoses, the concordance (or discordance)
between structured interviews and therapists’ evaluation,
the usefulness of asking for a second opinion,interob-
server reliability,and the test/retest reliability in scales
scoring.
In order to tailor therapy to the individual,the clinician
has information that can be classified into three differ-
ent sets.The first set consists of clinical trials findings
where patients were included in trials according to their
clinical characteristics and then randomized into treat-
ment subgroups on the basis of demographic or social
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Clinicians prescribe a medication when they assume that
there is a reasonable probability of its success. There are
many studies on the predictive value of social or clinical
information, but these studies do not include the prog-
nosis made by psychiatrists before treatment. These stud-
ies indicate that a small to moderate proportion of the
total variance of outcome can be predicted from social or
clinical information. It is peculiar that there are very few
studies on the accuracy of psychiatrists’ “bets” about the
effects of psychotropic drugs when they use the clinical
characteristics of patients as predictors, considering the
practical relevance of predicting the outcome of a psy-
chiatric treatment. The absence of studies on the accuracy
of clinicians’ bets or predictions in psychiatry is unfortu-
nate. 
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Clinical researchdata and scores on clinical scales.Results from clinical tri-
als are average results, giving an overall probability of
favorable response in a predefined patient population.
Controlled clinical trials are the basis for evidence-based
medicine,a method that is progressively being applied in
psychiatry.
The second set of information consists of local or
national opinions, or habits about the prescription of
medication.Clinical guidelines are an illustration of such
information;they combine information from evidence-
based medicine and expert consensus statements based
on clinical experience. The therapeutic image of psy-
chotropic medications is another illustration of this sec-
ond set:depending on the region,the period of time,or
the marketing activity of pharmaceutical industries,
physicians consider a molecule as having a given profile
of effects that might not correspond strictly to the facts
from clinical trials and evidence-based medicine.Many
years ago, we showed that even medical students can
have an image of a drug that does not correspond to the
known therapeutic efficacy
1:80% considered that cotri-
moxazole (rather than ampicillin) should be used to treat
acute urinary tract infection,while 80% considered that
ampicillin (rather than cotrimoxazole) should be used to
treat surinfection of chronic bronchitis—an unwarranted
distinction at that time.For the treatment of insomnia,
the prevalent choice among benzodiazepines (ie,the mol-
ecules selected most often by the responders) was the fol-
lowing:chlordiazepoxide for a chronic alcoholic patient,
nitrazepam for a healthy young man,and oxazepam for
an anxious menopausal woman.These answers were in
accordance with the local image of the drug, or local
belief.
1
The third set of information consists of personal opinions
derived from treating patients,from talking to colleagues,
and sometimes from wishful thinking or idiosyncratic
hypotheses.These three sets of information are used in
the decision process; this means that this process has
rational and irrational,and explicit and implicit compo-
nents.
Psychiatric disorders can be grouped into three cate-
gories on the basis of their evolution. Several run a
chronic course, with aggravation or little improvement
in core symptoms.This is the case for dementias,mental
deficiency syndromes, and schizophrenia. Fibromyalgia
is another disorder with an evolution characterized by
unremitting symptoms over years.For these types of dis-
orders, the prognosis, in the etymological sense of
“knowing the future,”can be made with facility so long
as one considers aspects of the disease for which no
treatment has ever been shown to influence the course.
Obviously,these aspects are unlikely to change,a situa-
tion that does not ask for competence in prediction.
However, there are accompanying symptoms and
comorbid disorders that can respond to treatment. For
example,antidementia or other drugs can modify behav-
ioral dyscontrol in dementia patients; agitation can be
favorably managed in mental retardation patients;and
fibromyalgia patients can make adaptations that
improve their quality of life. It is within the framework
of these improvements that the clinician should make
a prediction of treatment usefulness. Other psychiatric
disorders tend to run a favorable course, for example,
many of the acute stress reactions, when the stressor is
not too intense and when the threshold of severity
remains below the criteria for posttraumatic stress dis-
order or adjustment disorder. For these types of disor-
ders or situations, the challenge is to identify patients
whose evolution might not be spontaneously favorable.
Between these two categories of disorders—those show-
ing little improvement over time and those improving
spontaneously—there are disorders such as mood or
anxiety disorders that have an evolution that differs
from patient to patient,even when the baseline severity
of symptoms, before treatment, is the same. In these
cases,the range of possible outcomes is wide:from com-
plete,rapid,and even spontaneous resolution to death.
Table I indicates general aspects of outcome for which
a prediction should be systematically made in everyday
practice for all treatments and all patients. Patients
wish to be informed about the nature of these out-
comes, together with clinical comments on their prob-
ability.
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Table I. Aspects of outcome prediction.
Response versus nonresponse under treatment or no
treatment
Comparative efficacy of different treatments
Consequences of response or nonresponse on quality of life
Short-term risk of recurrence versus no recurrence under
treatment or no treatment
Long-term risk of recurrence versus no recurrence under
treatment or no treatment
Risk of occurrence of medication or psychotherapy side effects
Consequences of medication or psychotherapy side effectsStudies on predictive clinical variables
Variables can be measured at baseline,and then during
or at the end of the study,to explore how they relate to
outcome.Many prospective studies have been published
on the predictive value of clinical variables in psychiatry.
A selection of clinical variables included in these studies
is presented in Table II.
Studies on predictive variables establish to what extent
the outcome of a patient is strictly dependent on the
application of treatment,or whether,and to what extent,
patient-related characteristics influence outcome under
treatment.In statistical terms,the goal is to explore what
proportion of the variance of the dependent variable (eg,
clinical outcome) is explained by independent variables
(eg,sex,age,neuropsychological tests results,and comor-
bidity).Some of the studies were on the relationship of
single outcome measures with single predictors. For
example,pretreatment cognitive deficits signal an unfa-
vorable outcome of anorexia nervosa.
2 Other studies
used elaborate models, from general linear models to
artificial neural networks,
3 or complex models that com-
bine multivariate parametric statistics,artificial intelli-
gence, and linguistic qualitative judgments.A few pre-
dictive studies in the fields of anxiety and mood disorders
are summarized below.
Anxiety disorders
For anxiety disorders,comorbidity with personality disor-
ders appears to predict a lesser response or nonresponse
to treatment.
4-6 In a 5-year follow-up study of patients suf-
fering from anxiety disorders,182 out of 210 of those ini-
tially randomized to drug treatment, cognitive and
behavior therapy,self-help,or placebo were evaluated.
Sixty percent had a good outcome.Interestingly,clinical
evaluation of symptoms 10 weeks after the beginning of
treatment was among the strong predictors of outcome
5 years later, whatever the treatment was (even with
placebo).In this study,comorbid personality disorders
predicted a worse outcome.
7 Presence of hypochondria-
cal personality disorder (a personality disorder that is not
listed in the Diagnostic and Statistical Manual of Mental
Disorders,Fourth Edition [DSM-IV] classification sys-
tem) in 17 of the patients was particularly predictive of a
worse evolution of generalized anxiety, panic, or dys-
thymic disorder at 5 years.
8 Comorbidity of two anxiety
disorders can decrease the rate of response to treatment;
this was the case,for example,for posttraumatic stress
disorder and obsessive-compulsive disorder.
9
Mood disorders
In mood disorders,several clinical variables intuitively
expected to be predictors of evolution have not been
confirmed as such.This is particularly striking for per-
sonality disorders, which seem to have no predictive
value for outcome in several studies on antidepressant
treatments.
10-12 In fact,in these studies,the proportion of
patients who responded to the criteria of one or more
personality disorders decreased over the duration of
treatment,in line with what is known about the pharma-
cological treatment of Axis II personality disorders.
13,14
However,not all studies led to the conclusion that per-
sonality disorders do not influence the evolution of mood
disorders.Several studies indicate that personality disorders
do play a role;for example,the response to nortriptyline
was less in cases of avoidant personality disorder,
15 and
bipolar patients with an Axis II comorbid personality dis-
order tended to keep residual symptoms of depression
after remission.
9These differences might be explained by
the medications used 30 years ago comparative to the
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Table II. Clinical variables included in outcome prediction studies. DSM, Diagnostic and Statistical Manual of Mental Disorders.
DSM diagnosis, symptomatic aspects (configuration of symptoms, severity of symptoms, score on clinical scales)
DSM diagnosis, temporal aspects (age at onset, duration of the disorder, number of recurrences, delay until initiation of treatment)
Comorbidity (DSM-III or DSM-IV Axis I or Axis II, eg, personality disorders)
Demographic characteristics (age, gender, race)
Social variables (marital status, profession, income, social support)
Psychological characteristics (intelligence, years of education, insight, health belief model, etc)
Family variables (hereditary disorders, psychiatric or physical disorders in parents, expressed emotion)
Treatment-related variables (primary care or referral services, out- or inpatients, number of prior treatments, patients’ or therapists’
compliance, nature of treatment, dosage, and duration of treatment)present,or by the duration of follow-up,or by changes in
populations of patients included in the clinical trials.In a
5-year,follow-up study on 86 outpatients,the outcome of
dysthymic disorder was dependent on many clinical vari-
ables, such as Axis I or Axis II comorbidity and social
variables,such as early stressful events.
16
Studies on physicians’ predictions
In these studies, physicians indicate their prediction
about the outcome of individual patients and the accu-
racy of the prediction is tested against the actual clinical
evolution.Our search for such studies in the medical lit-
erature was a saddening experience:there are almost no
studies on therapists’ prediction in psychiatry! We did
find six studies.
In the first study,published more than 20 years ago,it was
stated that the evolution of 73 nonpsychotic patients
receiving psychoanalytically oriented psychotherapy
could not be predicted by the therapist.
17 The second
study concerned the comparative efficacy of psy-
chotherapy,relaxation,behavior therapy,and amitripty-
line in 155 patients followed for 3 months.The pretreat-
ment prediction of outcome by psychiatrists did not
correlate to patient outcome,particularly in the recov-
ered or the unremitted groups.
18 In the third study,nurses
and psychiatrists rated the likelihood of 308 hospitalized
patients of becoming violent.Both professional groups
achieved a good total predictive accuracy,with a propor-
tion of cases correctly predicted of 82% to 84%.
19 The
fourth study was on the specific issue of whether clini-
cians or patients could predict,or rather guess,whether
an active medication or a placebo was given.This was a
study of depression in child and adolescent outpatients;
it showed that clinicians,patients,or parents could not
adequately guess whether the patient had received flu-
oxetine or placebo.This was a study on a conditioned
probability, since the subjects knew the quality of the
clinical response at the time of their guess about treat-
ment.When the analysis was done taking into account
the clinical response at the end of 8 weeks,nonresponse
was a strong predictor that clinicians,patients,or parents
stated that patient was receiving placebo,while response
was a strong predictor that clinicians,patients,or parents
guessed that the patient was receiving the active com-
pound. The clinicians predicted medication for the
responders,ie,27 out of 31 patients and placebo for the
nonresponders,ie,26 out of 35 patients.These predictions
were not correct.
20The other studies were on the prog-
nostication of 100 alcoholics
21 and on the course of hos-
pitalization of 62 psychiatric patients.
22
The very limited number of studies in which the direct
prediction of clinicians was measured cannot be
explained by methodological problems,since there are
studies during which it would have been easy to add an
initial evaluation of patients’ future outcome by psychi-
atrists.Such data would not have been difficult to gather:
patient outcome could be expressed in simple terms,for
example,describing improvement on a 7-point scale such
as the clinical global impression (CGI) scale. A more
complete methodology would be to ask clinicians to list
several outcomes for each patient,and associate proba-
bilities to each of these outcomes.
We will describe a few studies on the variables influencing
outcome to demonstrate how unfortunate it is that the
simple issue of the quality of physicians’ bets quality was
not included in protocols.Fichter et al
23 studied 196 women
with bulimia nervosa purging type, 103 women with
anorexia nervosa,and 68 women with binge eating dis-
order.They used path analysis with 14 factors and found
many correlations,but only a few of these were statisti-
cally significant and related to the outcome of the
patients after 6 years.It might have been interesting to
compare this multifactorial statistical approach with the
performance of clinicians in predicting evolution.
Gabriels et al
24 studied 17 children with a diagnosis of
autism and organized a follow-up evaluation at a mean
duration of 40 months of treatment.The outcome was
not related to treatment;however,pretreatment devel-
opmental intelligence was higher in those with a better
outcome.Here also,it would have been easy to explore
whether clinicians could have made such a prediction.
Pyne et al
25 studied 59 inpatients with major depressive
disorder. They measured a series of variables chosen
from the literature for prediction of evolution in mood
disorders and, depending on the variables included,
obtained an accuracy value of 69% to 86%.Which accu-
racy levels would clinicians have reached,using clinical
information and intuition,had they been tested on this
question? Mulder et al
11 reported on 183 depressed out-
patients who completed a personality disorder assess-
ment and showed that 45% of them had at least one
comorbid personality disorder,but that this comorbidity
did not influence outcome. One exception was that
patients with a cluster C personality disorder responded
less well to nortriptyline than to fluoxetine.
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26 on the
development of a scale for early prediction of obsessive-
compulsive disorder response to treatment.The accuracy
of the scale was reasonable, with an area under the
receiver operator characteristic (ROC) curve of 0.71.
Here again,no attempt was made to obtain a prediction
from the clinicians. Clinical trials represent a valuable
source of information concerning predictors of outcome.
For example,the retrospective analysis of 1839 patients
in five placebo-controlled studies of venlafaxine pre-
scribed for general anxiety disorders showed that sleep
disturbance predicted positive response,while restless-
ness predicted poor response.Some variables,such as dif-
ficulty in concentrating or substance abuse history,pre-
dicted positive response to the placebo.
27The predictive
variables measured in the above studies have an obvious
clinical nature, and the absence of evaluation of clini-
cians’ performance in predicting outcome represents an
unfortunate missing aspect of these protocols.
Biological predictors of outcome
Physiological measures (eg,sleep architecture),pharma-
cological challenges (eg, the administration of psychos-
timulants), neuroendocrine baseline values (eg, mono-
amines, metabolites in plasma, urine, or spinal fluid),
neuroendocrine challenge studies (eg,dexamethasone or
corticotropin-releasing factor [CRF] tests) have been stud-
ied in biological psychiatry research studies for decades.
Several predictors of evolution have been identified in
these studies,and in a few cases,these predictors explained
one-quarter to one-half of the variance of outcome.More
recently, developments in pharmacogenomics have
opened new avenues for applying predictive medicine
techniques to psychiatric disorders.These biological pre-
dictive variables are described elsewhere in this issue of
Dialogues in Clinical Neuroscience.
Discussion
The concordance between psychiatrists’ predictions,
based on clinical impression and intuition,and the actual
outcome of psychiatric patients has not been studied cor-
rectly. Our search of the medical literature databases
(Medline,Excerpta Medica,and Psyclit) may have been
incomplete since it was limited to journal articles and did
not include chapters in books,but we doubt that this was
important.Thus,the publication by Luborsky et al
17 on
direct the prediction of psychotherapy outcome by ther-
apists (and patients,as well as clinical observers) and the
few other studies have not convinced researchers of the
value of knowing how clinicians forecast the evolution of
patients who receive psychiatric treatment,and of explor-
ing whether experienced clinicians are better at this than
beginners.In contrast,there are many prospective or ret-
rospective studies where the major goal was to find pre-
dictors of response in psychiatric patients.None of these
included clinicians' bets, and this is unfortunate. Two
major reviews on prognostic methods and outcome pre-
diction
28,29 contained no mention of the issue of physi-
cians’ individual bets on the basis of clinical data.These
bets were also not included in the development of an
artificial intelligence neural network to predict the need
for hospitalization of patients in 658 psychiatric emer-
gency room visits.
30
The lack of interest in clinicians’ direct predictions of
patient outcome in psychiatry is not found in internal
medicine,traumatology,oncology,or a few other medical
specialties.We summarize a few studies to illustrate their
relevance to clinical practice.An early study by Biorck
and collaborators
31 on the prediction of outcome of 100
consecutive myocardial infarction patients showed that
the prediction was quite accurate for those who had a
good prognosis or a bad one,but far from accurate for
those who had an intermediate risk;experienced physi-
cians did not make more accurate predictions.Another
study on a similar question indicated that physicians’
experience played little role in the accuracy of 3-year sur-
vival prediction after myocardial infarction, and that
mathematical models could surpass the physicians’ per-
formance.
32
In an evaluation of 402 internal medicine patients,6 physi-
cians achieved predictions of patients remaining alive
5 years later with a sensitivity greater than 0.8,indicating
that more than 80% of those surviving more than 5 years
were correctly identified as such at the time of hospital
discharge.The specificity was 0.6 to 0.8 depending on the
physician,indicating that nonsurvivors were identified as
such in 60% to 80% of cases.
33
Clinicians have a good capacity to predict patients’ sur-
vival during intensive care unit hospitalization, with
ROC curve areas of 0.85.
34 However,in another study on
713 estimates made by 51 physicians, the prediction of
survival after cardiac arrest and cardiopulmonary resus-
citation was no better than chance level.
35 Also, physi-
cians or nurses could not predict the quality of life in
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in an intensive care unit.
36 It was also difficult for physi-
cians to predict survival in cases of acute congestive heart
failure.
37The capacity of outcome prediction by internists,
surgeons,and neurologists has also been studied in cases
of patients having undergone severe traumas or burns.
These studies were motivated by the need to assess triage
decisions,in particular to identify patients too severely ill
to survive (and then restrict intensive care unit hospital-
ization or withdraw treatment to these patients).These
vital decisions are based on physicians’ predictions,and
it is fortunate that the accuracy of these decisions has
been a domain of research in intensive care medicine.
Clinicians have a synthetic and intuitive approach to the
prognosis of their patients, but there are no data from
which to decide whether to praise or criticize the quality
of psychiatrists’ predictions about outcome.The lack of
interest in the accuracy of psychiatrists’ direct predictions
could be seen as benign neglect:clinicians’ bets are only
one among the number of social,psychodynamic,or bio-
logical variables that could be included in research pro-
tocols on outcome prediction.We propose that this is not
benign neglect,for several reasons.First,doctors often
wonder about their capacity to predict patients’ evolu-
tion in the context of routine treatment,and they would
be interested in reading research findings on this issue.
Second, the absence of studies on the accuracy of psy-
chiatrists’ predictions of patients’ outcome could be inter-
preted as a refusal to look into the important question of
whether doctors have any idea about the consequence of
their prescriptions. Such studies would answer the fol-
lowing question: do we, as clinicians, have any compe-
tence in prognostication that is better than chance level?
Is it more comfortable to keep ignoring the answer than
to confront ourselves with the possible conclusion that
we are no good at predicting the clinical outcome of
patients? Third,there is the obvious fact that psychiatrists
are confronted daily with demands of predicting the risk
that patients might not respond to treatment,might need
to be hospitalized,might become violent,or might com-
mit suicide. Complex multivariate predictive models
including clinical and biological variables are being stud-
ied and will become available to psychiatrists in every-
day practice.A better capacity and confidence in prog-
nostication in the practice of psychiatry will represent a
significant change,and help us forget that we have been
working for decades not knowing the accuracy of our
direct clinical predictions of patient outcome. ❏
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Predicciones de los clínicos acerca de la
respuesta del paciente a los psicofármacos
Los clínicos prescriben un medicamento cuando
suponen que existe una probabilidad razonable de
éxito. Hay muchos estudios sobre el valor predictivo
de la información social o clínica, pero dichos estu-
dios no incorporan el pronóstico que efectúan los
psiquiatras antes del tratamiento. Dichos estudios
señalan que una proporción pequeña a moderada
de la variación total de la evolución se puede pre-
decir a partir de la información social o clínica.
Llama la atención que existen muy pocos estudios
sobre la precisión de las “apuestas” de los psiquia-
tras acerca de los efectos de los psicofármacos
cuando se utilizan, como predictores, las caracte-
rísticas clínicas de los pacientes, tomando en cuenta
la importancia práctica que tiene la predicción de
la evolución de un tratamiento psiquiátrico. La falta
de estudios sobre la precisión de las apuestas o de
las predicciones de los clínicos representa una
ausencia desafortunada en la psiquiatría.
Prédictions faites par les cliniciens au sujet
de la réponse du patient aux médicaments
psychotiques
Les cliniciens prescrivent des médicaments lorsqu’ils
considèrent que la probabilité de succès du traite-
ment est suffisante. Il existe de nombreuses études
portant sur la valeur prédictive de données sociales
ou cliniques, mais les pronostics faits par les psy-
chiatres avant traitement n’ont pas été inclus dans
de telles études. Ces études indiquent qu’une pro-
portion modeste à modérée de la variance totale de
l’évolution clinique peut être prédite à partir des
informations sociales ou cliniques. Il est étonnant de
constater qu’il y a si peu d’études sur l’exactitude des
paris des psychiatres au sujet des effets des médica-
ments psychotropes, paris fondés sur les caractéris-
tiques cliniques des patients comme prédicteurs, sur-
tout si l’on considère l’importance pratique de
prédire l’évolution sous un traitement psychiatrique.
L’absence d’études portant sur l’exactitude des paris
ou des prédictions faits par les cliniciens est regret-
table dans le domaine de la psychiatrie.
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